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Abstract To estimate the prevalence of refractive error in
adults across Europe. Refractive data (mean spherical
equivalent) collected between 1990 and 2013 from fifteen
population-based cohort and cross-sectional studies of the
European Eye Epidemiology (E3) Consortium were com-
bined in a random effects meta-analysis stratified by 5-year
age intervals and gender. Participants were excluded if they
were identified as having had cataract surgery, retinal
detachment, refractive surgery or other factors that might
influence refraction. Estimates of refractive error preva-
lence were obtained including the following classifications:
myopia B-0.75 diopters (D), high myopia B-6D, hy-
peropia C1D and astigmatism C1D. Meta-analysis of re-
fractive error was performed for 61,946 individuals from
fifteen studies with median age ranging from 44 to 81 and
minimal ethnic variation (98 % European ancestry). The
age-standardised prevalences (using the 2010 European
Standard Population, limited to those C25 and \90 years
old) were: myopia 30.6 % [95 % confidence interval (CI)
30.4–30.9], high myopia 2.7 % (95 % CI 2.69–2.73), hy-
peropia 25.2 % (95 % CI 25.0–25.4) and astigmatism
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23.9 % (95 % CI 23.7–24.1). Age-specific estimates re-
vealed a high prevalence of myopia in younger participants
[47.2 % (CI 41.8–52.5) in 25–29 years-olds]. Refractive
error affects just over a half of European adults. The
greatest burden of refractive error is due to myopia, with
high prevalence rates in young adults. Using the 2010
European population estimates, we estimate there are 227.2
million people with myopia across Europe.
Keywords Refractive error  Myopia  Epidemiology 
Prevalence  Consortium
Introduction
Refractive error occurs when there is failure of the eye to
correctly focus rays of light from an object onto the retinal
plane. The resultant image perceived by the individual is
blurred and refractive correction is required in order to see
clearly. Refractive error can be divided into myopia (‘short
or near-sightedness’), hyperopia (‘long or far-sightedness’)
and astigmatism. In myopia, light is focussed to a point
anterior to the retina as a result of excessive refraction at
the cornea or lens, or, more commonly, an increased length
of the eye (‘axial myopia’). In hyperopia, the reverse oc-
curs with an image forming posterior to the retinal plane as
a result of either inadequate refraction or a short axial
length. In astigmatism, the refractive power of the eye is
uneven across different meridians.
Refractive error requires detection and treatment in the
form of glasses, contact lenses or, more recently, refractive
surgery. These clinical services are readily available in most
European countries, although they come with significant fi-
nancial implications to both national health care systems and
to individuals [1]. However, uncorrected refractive errors are
still responsible for up to 42 % of the cases of visual
impairment worldwide [2], and remain prevalent even in
high income countries [3–6]. Uncorrected refractive error in
both low and high-income countries has significant eco-
nomic implications in terms of potential lost productivity [7].
The magnitude of refractive error in developed countries
within individuals of European descent has been estimated
by the Eye Diseases Prevalence Research Group, 10 years
ago, and the US National Health and Nutrition Examina-
tion Survey (NHANES) data [3, 8]. However, the estimate
of refractive error burden in Europe was based on a single
cohort [9]. The European Eye Epidemiology (E3) consor-
tium is a collaborative initiative between thirty-three cohort
studies across Europe, to share and meta-analyse epi-
demiological data on eye disease in adults. The aim of the
current study was to provide more current and precise es-
timates of the prevalence of refractive error across Europe.
Materials and methods
Studies and participants
To date, E3 has data from thirty-three studies with a range
of ophthalmic data on approximately 124,000 individuals
from population-based and case–control studies. This study
drew on the fifteen E3 population-based cohort and cross-
sectional studies that collected refractive error data
(n = 68,350). As described in Table 1, participants in-
cluded in this meta-analysis were largely from Northern
and Western Europe, mainly of middle to late age, and
refractive error measurements were performed between
1990 and 2013. Three studies recruited participants na-
tionally and the remaining twelve recruited from a local
population. Further detail on individual study design and
sampling method is provided in the supplementary infor-
mation; broadly, the majority of study samples were ob-
tained by identification of potential participants (within
defined age bands and/or regions) using local registries,
with some studies using random sampling (n = 3). All
studies adhered to the tenets of the Declaration of Helsinki,
and relevant local ethical committee approvals with
specific study consent were obtained.
Inclusion and exclusion criteria
Studies in the E3 consortium were eligible for inclusion in
this analysis if they were population-based, and data on
refraction, together with age at measurement and year of
birth, were available. Study participants were excluded if
they were identified as having had cataract surgery, retinal
detachment, refractive surgery or other factors that might
influence refraction (e.g. keratoconus), at the discretion of
each study’s analysis team.
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Biostatistique, 33000 Bordeaux, France
16 Department of Ophthalmology, Aristotle University of
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Group UMR 1324 INRA, Univerisity Hospital Dijon, Dijon,
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18 NIHR Biomedical Research Centre, Moorfields Eye Hospital
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Germany
20 Institute of Human Genetics, Klinikum Rechts der Isar,
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Demographic and outcome variables
All included studies measured non-cycloplegic refraction
(i.e. no dilating drops were used) using the technique of
subjective refraction, autorefraction or a combination of
focimetry (measuring an individuals glasses) or autorefrac-
tion followed by subjective refraction (Table 1). Par-
ticipant’s spherical equivalent (SE) was considered as the
mean SE of the two eyes calculated using the standard for-
mula (SE = sphere ? (cylinder/2)). Refractive error was
categorized using the following definitions: myopia B-0.75
diopters (D), low myopia B-0.75 to[-3D, moderate my-
opia B-3D to[-6D, high myopia B-6D, hyperopia C1D,
high hyperopia C3D and astigmatism C1D. Definitions of
myopia vary in the literature; the cut-off of -0.75D was
chosen as unaided visual acuity at this level approximates 0.3
LogMAR (Logarithm of the Minimum Angle of Resolution)
[10], a commonly used driving standard, and this has been
used in recent international meta-analyses of the genetic
epidemiology of refractive error and myopia [11].
Differences in age (in 5 year age bands from C15 to
C90 years), gender (male/female) and geographical Euro-
pean region were examined. Geographical variations in the
prevalence of myopia were investigated by dividing
countries in three areas (Northern, Western and Southern
Europe) according to the United Nations Geoscheme [12].
Information on ethnicity, when available, was recorded
using a modified classification system based on genetic
ancestry [13].
Statistical analysis
Study specific summary data were obtained. A random
effects meta-analysis was performed for spherical equiva-
lent and repeated for refractive classifications overall and
stratified by age. This enabled calculation of pooled esti-
mates of refractive error prevalence, with studies weighted
by sample size and between-study variance and a summary
estimate standard error calculated from the inverse sum of
the adjusted weights. A random effects model was chosen
over a fixed effects model, to allow for heterogeneity in
study design characteristics.
Age-standardised prevalences were calculated using the
following steps: firstly, age-specific prevalences were es-
timated using random-effect meta-analyses. Secondly, an
age-standardisation with adjustments to age-specific esti-
mates according to the European Standard Population 2010
was performed [14]. This enabled refractive error preva-
lence estimates that are representative for the European
population, with appropriate weighting to the age demo-
graphic distribution of Europe.
Subsequent random effects meta-analyses were per-
formed with stratification by age and gender, and
subsequently age and geographical region, with differences
between groups evaluated using ANOVA tests.
Statistical analysis was performed using Stata version
13.1 (StataCorp. 2013. Stata Statistical Software: Release
13. College Station, TX: StataCorp LP). Graphical outputs
were obtained using either Stata or ggplot2 [15] in R (R
Core Team (2014). R: A language and environment for
statistical computing. R Foundation for Statistical Com-
puting, Vienna, Austria. URL http://www.R-project.org).
Results
Fifteen studies contributed a total of 61,946 individuals
after exclusions (Fig. 1). The median age of the included
populations ranged from 44 to 78 years old (Table 1).
There was a slight female predominance in the combined
study (57.6 % females). Data on ethnicity was only avail-
able for 50 % of participants, and in these there was
minimal ethnic diversity (98 % European ancestry), so no
further analysis of ethnicity was carried out.
The distribution of refractive error displayed a lep-
tokurtotic distribution (Fig. 2), with a median spherical
equivalent of 0.56D (range -25.13–22.19). The distribu-
tion was asymmetric with a greater frequency of indi-
viduals with a negative refractive error.
Given there were only 314 participants aged
15–24 years and 156 [90 years of age, subsequent ana-
lyses are limited to those aged C25 and \90 years
(n = 61,476). The overall myopia prevalence in our meta-
analysis was 24.2 % (95 % confidence interval (CI) CI
19.9–28.5), with a European age-standardised myopia
prevalence of 30.6 % (95 % CI 30.4–30.9; Table 2). My-
opia was most common in younger participants [peaking at
47.2 % (95 % CI 41.8–52.5) in those aged 25–29 years],
almost double the prevalence of those of middle and older
age [27.5 % (95 % CI 23.5–31.5) in those aged
55–59 years; Fig. 3a]. Point estimates of myopia preva-
lence in those aged 15–19 years were 27.4 % (95 % CI
17.0–37.8), increasing to 34.2 % (95 % CI 27.9–40.6) in
those aged 20–24 years. All degrees of myopia followed a
similar pattern of higher prevalence in the younger cohorts,
lower prevalence in the middle aged and more elderly
participants, and an increase in the very eldest participants,
albeit with wide CIs, most likely related to cataract de-
velopment. Age-standardised prevalence of high myopia
across all age groups was 2.71 % (95 % CI 2.69–2.73),
with 3–5 % of young to middle-aged individuals affected
and 1–2 % of older individuals (Fig. 3b).
Overall prevalence of hyperopia was 34.7 % (95 % CI
27.9–41.6), with an age-standardised prevalence of 25.2 %
(95 % CI 25.0–25.4). There was less hyperopia in young
participants [6.4 % (95 % CI 3.8–9.0) in those aged
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25–29 years], compared to those in middle to older age
[31.2 % (95 % CI 27.5–34.9) in those aged 55–59 years]
although hyperopia rates declined after 75 years of age.
The prevalence of high hyperopia followed a similar pat-
tern, affecting 1–3 % of younger and 10–13 % of older
individuals (Fig. 3c). Across all ages, the prevalence of
astigmatism was 27.3 % (95 % CI 22.6–32.1) with an age-
standardised estimate of 23.9 % (95 % CI 23.7–24.1). The
prevalence of astigmatism remained fairly stable at
15–25 % in young and middle-aged participants [17.0 %
(95 % CI 15.1–18.8) in those aged 45–49 years]. How-
ever, in participants over 65 years of age, astigmatism
became more common [51.1 % (95 % CI 40.4–61.8) in
those aged 80–84 years; Fig. 3d].
Age- and gender- specific analyses for myopia, hyper-
opia and astigmatism are reported in Table 3. There were
no significant differences in myopia prevalence between
men and women across age strata. However, overall there
was a significantly higher prevalence of astigmatism in
men (p = 0.001), with a mean difference of 3.8 % across
all ages, and a significantly higher prevalence of hyperopia
in women (p = 0.04) with a mean difference of 2.5 %
across all ages.
Differences in the myopia prevalence between different
European regions, according to the UN European Geo-
scheme, were examined. Only one cohort contributed to
the Southern European division (Thessaloniki Eye Study,
Greece), with participants all over the age of 60 years, thus
the majority of the studies were in Northern and Western
regions. The prevalence of myopia did not differ between
Northern and Western countries and followed a similar
pattern across all age groups. The single Southern par-
ticipant cohort appeared to have a higher level of myopia
in its older participants when compared to Northern and
Western countries, however there were large CIs for these
estimates (80–84 year-old myopia prevalence in North
13.6 % (95 % CI 9.3–18.0), West 18.0 % (95 % CI
16.1–21.1) and South 29.1 % (95 % CI 19.1–39.1).
Overall there were no significant differences across age
strata between the three regions of Europe studied
(p = 0.70).
Discussion
Meta-analysed data from fifteen population-based adult
cohort and cross-sectional studies across Europe indicated
age-standardised prevalence of 30.6 % for myopia, 25.2 %
for hyperopia and 23.9 % for astigmatism. This meta-
analysis usefully incorporates data from across Europe and
is not limited to a particular place or age group. The most
significant burden of refractive error within Europe was
from myopia.T
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A clear trend of higher levels of myopia in younger
individuals was identified, with a rising prevalence during
late teens and 20 s reflecting the known natural history of
the condition [16]. The peak prevalence of myopia was
identified in the 25–29 years age group (47.2 % (95 %
41.8–52.5). In older individuals, the prevalence of myopia
was lower, for example 15.9 % (95 % CI 13.7–18.1) in
those aged 65–69 years old. This may reflect the rising
prevalence of myopia in younger generations, or the known
hyperopic shift in aging [17, 18]. In our aged 75 or over
participants, there was an increase in myopia prevalence.
While we aimed to exclude those having undergone cat-
aract surgery (and participants with documented cataract in
some studies), the rise in myopia likely reflects the de-
velopment of nuclear cataract, which is known to be as-
sociated with a myopic shift as a result of increasing lens
power [19]. However, this age-related change in refraction
may also occur irrespective of visible lens opacity; in the
Beaver Dam Study, a 10-year longitudinal myopic shift
(-0.19D, 95 % CI -0.32 to -0.06, p \ 0.001) was ob-
served in those over 70 years old, even after adjusting for
nuclear sclerosis grading [17]. We did not confirm the
observation of previous studies of higher myopia preva-
lence in women [20].
In comparison to previous estimates, the overall burden
of myopia in our population appears similar but slightly
greater to that of other studies. The 2004 Eye Diseases
Prevalence Research Group estimated myopia prevalence
at 26.6, 25.4 and 16.4 % for European, North American
and Australian sub-analyses respectively [8]. This study
included the Beaver Dam Eye Study [21], the Baltimore
Eye Survey [22], the Blue Mountains Eye Study [23], the
Melbourne Visual Impairment Project [24] and the Rot-
terdam Study I [9], which was also included in this meta-
analysis. In their youngest cohort (40–49 years), 36.8 % of
white men and 46.3 % of white women were myopic,
similar to our estimates of 42.0 and 39.8 % in 40–44 year-
olds, albeit with no gender difference. The US 1999–2004
NHANES examined refractive error variation by age in
three ethnicities; the prevalence of myopia in non-Hispanic
white participants 20–39 years of age was 35.1 % in men
and 42.3 % in women, whilst the prevalence in those
C60 years was 23.1 % in men and 18.6 % in women [20].
These prevalence rates are again very similar to that found
in our data, although we did not find higher levels of my-
opia in young females. Both comparative estimates are
based on a definition of myopia B-1D, and are therefore
not directly comparable to our study definition of myopia
B-0.75D, an issue often encountered in refractive error
epidemiology where there is a lack of consensus on
definitions of refractive error. The adult prevalence of
myopia in South-east Asia is of much greater magnitude
than that seen in studies of European ancestry [25–28],
with remarkably high levels of myopia seen in young in-
dividuals [29, 30]. The number of participants in our meta-
analysis of Asian origin was very low, precluding mean-
ingful reporting of these estimates.
High myopia prevalence was relatively low in Europe,
with an age-standardised estimate of 2.7 % (95 % CI
2.69–2.73). The highest prevalence was observed in
younger participants, albeit with wider CIs due to smaller
sample size (Table 2). Prevalence in older participants was
low, potentially reflective of generational changes, or per-
haps exclusion due to the earlier need for cataract surgery
in high myopes compared to other refractive groups [31].
Fig. 1 Flow chart of refractive error meta-analysis within E3
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Our greatest high myopia prevalence of 5.9 % (95 % CI
1.3–10.5) in 15–19 year-olds remains much lower than that
seen in, for example, urban China where up to 14 % of
17 year-olds are highly myopic [32]. In non-Hispanic
White individuals in the NHANES 1999–2004 data, high
myopia appeared slightly more common than in our data;
for example in those aged 20–29 years-old ‘‘severe’’ my-
opia was identified in 7.4 %, compared to 2.8 and 5.3 % in
those aged 20–24 and 25–29 respectively in this European
study. However the NHANES definition of severe myopia
(B-5D) again differs slightly from our definition of high
myopia (B-6D).
Using the same definition of high hyperopia (C 3D), our
study appeared to have less hyperopia than the Eye Dis-
eases Research Group [8]; for example in 70–74 year-olds
21.3 % of white women and 16.9 % of white men were
highly hyperopic compared to just 12.8 % in our European
data, which may again reflect a generational or cohort
effect.
Astigmatism rates were fairly constant (15–25 %) across
cross-sectional age categories, but were higher after the age
of 65. This finding has been observed in other studies,
together with a shift from with-the-rule to against-the-rule
astigmatism [20, 23, 28]. Across all age groups, we iden-
tified higher astigmatism prevalence in men, particularly
evident in middle to later ages (for example 39.5 % in
women and 46.2 % in men aged 70–74). This observation
was similar in the older participants of the NHANES
1999–2004 study, where in participants over the age of
60 years the astigmatism prevalence in women was 46.1 %
and in men 54.9 % [20].
The major strength of our study is the large sample size
contributing to the prevalence estimates, providing a
unique opportunity to estimate the burden of refractive
error in middle and older aged individuals across Europe.
This is beneficial for planning of clinical services and
raises awareness, for both clinicians and economists, of the
future potential issues of rising myopia levels and associ-
ated visual impairment [33]. Refractions were all non-cy-
cloplegic, which is common practice for population-based
adult ophthalmic epidemiological studies, thus making this
study comparable to previous research [34, 35].
Despite age and gender stratification, significant
heterogeneity between studies remained in the meta-
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analysis. There are inherent differences in the included
studies in terms of study design, refraction technique and
cohort sampling, together with between country differences
in levels of urbanisation, economy, education and climate
which may influence refractive error. We were unable to
stratify by these factors in this meta-analysis as person-
specific data was not available for all studies. This study
was mainly comprised of middle and older aged indi-
viduals, therefore our estimates of refractive error preva-
lence carry greater confidence for these ages since they are
based on more precise estimates with narrow 95 % CIs.
The majority of the studies in this meta-analysis originate
from Northern and Western European countries, and
therefore our estimates of refractive error are more repre-
sentative of these European countries. Although our sample
includes either national or locally recruited population-
based studies, like all epidemiological studies there may be
a bias of participants volunteering for an eye examination
being more ‘health conscious’. We suspect this would have
little effect on the prevalence of refractive error, and if
anything result a slight underestimation of the prevalence.
Finally, refractions were performed over a twenty-year
period and, therefore our estimates of prevalence may be
subject to error given temporal trends in refractive error
prevalence. However, refractions were performed between
2000 and 2010 in thirteen out of the fifteen studies, re-
ducing this variability.
In conclusion, this study estimates refractive error af-
fects just over a half of European adults. Myopia repre-
sented the greatest burden, with an estimated 227.2 million
people across Europe affected (using the 2010 European
population estimates) [36]. Based on study prevalence es-
timates of high myopia, this also suggests there are 20.1
million people across Europe who are at higher risk of the
associated sight threatening complications, such as retinal
detachment, that this degree of myopia confers [33].
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